Proceedings of the 1st International Conference on Lifestyle Diseases and Natural Medicine (ICOLIFEMED 2024)

Anticancer Effects of Vitex trifolia Extract on Cervical Cancer Animal Models: A Study of Genetic Mutations and Anti-Apoptotic Bcl-2 Gene Expression

Authors
Humairah Medina Liza Lubis1, *, Emni Purwoningsih2, Anggi Yulisna Frisilia Saputri3
1Department of Anatomical Pathology, Faculty of Medicine, Universitas Muhammadiyah Sumatera Utara, Jl Gedung Arca No 53 – 20217, Medan, Indonesia
2Department, Muhammadiyah University of North Sumatera, Medan, Indonesia
3Faculty of Medicine, Universitas Muhammadiyah Sumatera Utara, Jl Gedung Arca No 53 – 20217, Medan, Indonesia
*Corresponding author. Email: humairahmedina@umsu.ac.id
Corresponding Author
Humairah Medina Liza Lubis
Available Online 31 March 2025.
DOI
10.2991/978-94-6463-664-2_19How to use a DOI?
Keywords
Vitex trifolia; Cervical Cancer; Genetic Mutations; Anti-Apoptotic Bcl-2; Resistance
Abstract

This study investigates the potential of Vitex trifolia (legundi) extract to reduce resistance to radiation and chemotherapy in epithelial cancer by targeting the Bcl-2 apoptosis pathway. The objectives include (1) characterizing Casticin and Labdane-Type Diterpene compounds; (2) analyzing Bcl-2 gene mutations in chemotherapy resistance; (3) studying molecular docking interactions with Bcl-2 protein; (4) evaluating histopathological effects in cervical cancer animal models; (5) assessing apoptosis via Bcl-2 expression changes; and (6) ensuring safety through liver and kidney function tests. Using in vitro and in vivo methods, the study employed phytochemical screening, molecular docking, and a rat cervical cancer model treated with Vitex trifolia extract. GC-MS confirmed the presence of Casticin and Labdane-Type Diterpene. Molecular docking revealed strong interactions between Labdane-Type Diterpene and Bcl-2. Histopathological improvements and reduced Bcl-2 expression were observed, suggesting Vitex trifolia extract could enhance cancer treatment efficacy by overcoming chemotherapy resistance.

Copyright
© 2025 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 1st International Conference on Lifestyle Diseases and Natural Medicine (ICOLIFEMED 2024)
Series
Advances in Health Sciences Research
Publication Date
31 March 2025
ISBN
978-94-6463-664-2
ISSN
2468-5739
DOI
10.2991/978-94-6463-664-2_19How to use a DOI?
Copyright
© 2025 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Humairah Medina Liza Lubis
AU  - Emni Purwoningsih
AU  - Anggi Yulisna Frisilia Saputri
PY  - 2025
DA  - 2025/03/31
TI  - Anticancer Effects of Vitex trifolia Extract on Cervical Cancer Animal Models: A Study of Genetic Mutations and Anti-Apoptotic Bcl-2 Gene Expression
BT  - Proceedings of the 1st International Conference on Lifestyle Diseases and Natural Medicine (ICOLIFEMED 2024)
PB  - Atlantis Press
SP  - 194
EP  - 218
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-664-2_19
DO  - 10.2991/978-94-6463-664-2_19
ID  - Lubis2025
ER  -